Twice Rejected Diabetes Drug/Device Product Gets New Chance at Startup i2O

Intarcia Therapeutics’ GLP-1 agonist product candidate for type 2 diabetes now belongs to i2O Therapeutics, which will make the treatment’s case for approval at an upcoming FDA advisory committee meeting. The startup’s $46 million Series A financing is one of several recently announced funding rounds.

Related Keywords

Shanghai ,China ,New Jersey ,United States ,San Diego ,California ,Boston ,Massachusetts ,Harvard University ,Qiming ,Sichuan ,Samir Mitragotri ,Andreesen Horowitz ,Redmile Group ,Rd Fund ,Bain Capital Life Sciences ,Intarcia Therapeutics ,Sanofi Ventures ,Epigenic Therapeutics ,Qiming Venture Partners ,Morningside Venture Capital ,Superluminal Medicine ,San Francisco Based Cellares ,Koch Disruptive ,Rapport Therapeutics ,Asset Management ,Genesis Therapeutics ,Medcity News ,Bain Capital Life ,Weight Loss ,Obesity ,Verweight ,Diabetes ,Medical Devices ,Startups ,Healthcare Innovation ,San Francisco ,Life Sciences ,Accelerator ,Rock Health ,Startup Advice ,Startup Funding ,Patient Monitoring System ,Otion Sensors ,Dc ,Healthcare It ,Washington ,Foodborne Pathogens ,Iagnostics Company ,Iagnostic Platforms ,Minimally Invasive Surgery ,Aser Surgery ,Cambridge ,Dealflow ,Hospitals ,Wellpoint ,Ealthways ,Ealth And Wellness ,Mployee Wellness Programs ,Investing ,Wellness ,Medtronic ,Hanghai Innovation Center ,R D ,Mdt ,Minneapolis ,Minnesota ,Publics ,Twin Cities ,Ulcerative Colitis ,Abbott Labs ,Humira ,Doctors ,Pharmaceuticals ,Skin Disorders ,D Anderson Cancer Center ,Cancer ,Texas ,Renal Denervation ,St Jude Medical ,Stj ,Emr ,Hr ,Electronic Health Records ,Electronic Medical Records ,Certified Emr ,Ehr ,Advanced Cellular Technology ,Amyotrophic Lateral Sclerosis ,Embryonic Stem Cells ,Geron Corporation ,Lou Gehrigs Disease ,Macular Degeneration ,Regenerative Medicine ,Spinal Cord Damage ,Value Based Healthcare System ,Obamacare ,Ee For Service Model ,Cleveland ,Health Insurance ,Insurance ,Ohio ,Pennsylvania ,Politics ,Cancer Treatment Options Library ,Aetna ,Pet ,Aet ,Health It ,Phi ,Philadelphia ,Biopharma Nl ,Fda ,H2o Therapeutics ,Medical Device ,Venture Capital , ,